| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1048549006 |
| P356 | DOI | 10.1007/S11259-011-9487-5 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s11259-011-9487-5 |
| P698 | PubMed publication ID | 21681550 |
| P50 | author | Denis R. Verwilghen | Q43289737 |
| P2093 | author name string | Yves Henrotin | |
| Ann Martens | |||
| Didier Serteyn | |||
| Thierry Franck | |||
| Evita Busschers | |||
| Laurent Vanderheyden | |||
| Michelle Deberg | |||
| P2860 | cites work | Relationship between biochemical markers and radiographic scores in the evaluation of the osteoarticular status of Warmblood stallions | Q83505380 |
| Mechanism of reaction of myeloperoxidase with nitrite | Q28116231 | ||
| Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly | Q29547442 | ||
| Plasma myeloperoxidase level and polymorphonuclear leukocyte activation in horses suffering from large intestinal obstruction requiring surgery: preliminary results | Q33923571 | ||
| Myeloperoxidase and chlorinated peptides in osteoarthritis: potential biomarkers of the disease | Q34196527 | ||
| Myeloperoxidase produces nitrating oxidants in vivo | Q34791672 | ||
| Classification of osteoarthritis biomarkers: a proposed approach. | Q36491949 | ||
| Type II collagen markers in osteoarthritis: what do they indicate? | Q36925336 | ||
| Scapulohumeral osteochondrosis. A retrospective study of 32 horses. | Q37326411 | ||
| Biochemical biomarkers of oxidative collagen damage. | Q37641274 | ||
| Biomarkers of cartilage turnover. Part 1: Markers of collagen degradation and synthesis | Q37757754 | ||
| Plasma concentrations of a type II collagen-derived peptide and its nitrated form in growing Ardenner sound horses and in horses suffering from juvenile digital degenerative osteoarthropathy | Q39783480 | ||
| Synoviocytes, not chondrocytes, release free radicals after cycles of anoxia/re-oxygenation | Q40394951 | ||
| Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients | Q42283943 | ||
| Collagen fibril disruption occurs early in primary guinea pig knee osteoarthritis | Q42909168 | ||
| A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species | Q43904660 | ||
| Spatial mapping of pulmonary and vascular nitrotyrosine reveals the pivotal role of myeloperoxidase as a catalyst for tyrosine nitration in inflammatory diseases | Q44166458 | ||
| Inhibition of antigen-induced arthritis in guinea pigs by a selective LTB4 receptor antagonist LY293111Na | Q44286049 | ||
| Development of an enzyme-linked immunosorbent assay for specific equine neutrophil myeloperoxidase measurement in blood. | Q48748959 | ||
| Evaluation of serum concentrations of biomarkers of skeletal metabolism and results of radiography as indicators of severity of osteochondrosis in foals. | Q51028346 | ||
| Racing performance of standardbreds after conservative and surgical treatment for tarsocrural osteochondrosis. | Q51051629 | ||
| The effects of lifetime food restriction on the development of osteoarthritis in the canine shoulder. | Q53161505 | ||
| Depolymerization of synovial fluid hyaluronic acid (HA) by the complete myeloperoxidase (MPO) system may involve the formation of a HA-MPO ionic complex | Q68078077 | ||
| Production of active oxygen species by isolated human chondrocytes | Q70467317 | ||
| NMR studies on human, pathologically changed synovial fluids: role of hypochlorous acid | Q71354973 | ||
| Even low‐grade synovitis significantly accelerates the clearance of protein from the canine knee: implications for measurement of synovial fluid “markers” of osteoarthritis | Q71970882 | ||
| Alterations in cartilage type-II procollagen and aggrecan contents in synovial fluid in equine osteochondrosis | Q74151063 | ||
| Nitric oxide downregulates interleukin 1beta (IL-1beta) stimulated IL-6, IL-8, and prostaglandin E2 production by human chondrocytes | Q77123635 | ||
| Excessive degradation of type II collagen in articular cartilage in equine osteochondrosis | Q78629122 | ||
| A type II-collagen derived peptide and its nitrated form as new markers of inflammation and cartilage degradation in equine osteochondral lesions | Q79741940 | ||
| Cartilage-derived biomarkers and lipid mediators of inflammation in horses with osteochondritis dissecans of the distal intermediate ridge of the tibia | Q79832067 | ||
| Plasma concentrations of myeloperoxidase in endurance and 3-day event horses after a competition | Q80083082 | ||
| Type II collagen peptides for measuring cartilage degradation | Q80426071 | ||
| One-year follow-up of Coll2-1, Coll2-1NO2 and myeloperoxydase serum levels in osteoarthritis patients after hip or knee replacement | Q80651272 | ||
| Measurement of equine myeloperoxidase (MPO) activity in synovial fluid by a modified MPO assay and evaluation of joint diseases - an initial case study | Q80735131 | ||
| One-year increase of Coll 2-1, a new marker of type II collagen degradation, in urine is highly predictive of radiological OA progression | Q81195723 | ||
| The chemical biomarkers C2C, Coll2-1, and Coll2-1NO2 provide complementary information on type II collagen catabolism in healthy and osteoarthritic mice | Q81377189 | ||
| New serum biochemical markers (Coll 2-1 and Coll 2-1 NO2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritis | Q81433688 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 401-408 | |
| P577 | publication date | 2011-06-17 | |
| P1433 | published in | Veterinary Research Communications | Q15761009 |
| P1476 | title | Coll2-1, Coll2-1NO2 and myeloperoxidase concentrations in the synovial fluid of equine tarsocrural joints affected with osteochondrosis | |
| P478 | volume | 35 |
| Q33655900 | Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial |
| Q91847366 | Osteochondritis dissecans (OCD) in Horses - Molecular Background of its Pathogenesis and Perspectives for Progenitor Stem Cell Therapy |
| Q38723831 | Review of Soluble Biomarkers of Osteoarthritis: Lessons From Animal Models |
Search more.